|
Market Closed -
Toronto S.E.
23:59:56 14/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 13.38 CAD | -3.39% |
|
-2.55% | +68.94% |
Company Valuation: Satellos Bioscience Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
| Market Cap 1 | 6.794 | 36.73 | 95.65 | 89.3 | 200.8 | - | - |
| Change | - | 440.53% | 160.46% | -6.65% | 124.93% | - | - |
| Enterprise Value (EV) 1 | 6.794 | 36.73 | 46.68 | 89.3 | 107.2 | 89.5 | 17.05 |
| Change | - | 440.53% | 27.11% | 91.29% | 20.05% | -16.51% | -80.95% |
| P/E | - | - | -3.32x | -3.36x | -4.14x | -6.15x | -5.99x |
| PBR | - | - | - | - | 4.82x | 4.51x | - |
| PEG | - | - | - | 0.2x | -0.1x | 0.2x | -2.28x |
| Capitalization / Revenue | - | - | - | - | - | - | 35.5x |
| EV / Revenue | - | - | - | - | - | - | 3.01x |
| EV / EBITDA | - | - | - | -3.38x | -4.29x | -3.23x | -0.61x |
| EV / EBIT | -1.08x | -3.23x | -2.4x | -3.37x | -2.85x | -2.2x | -0.36x |
| EV / FCF | - | - | -2.67x | - | -2.55x | -2.37x | -0.33x |
| FCF Yield | - | - | -37.5% | - | -39.2% | -42.3% | -305% |
| Dividend per Share 3 | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - |
| EPS 3 | - | - | -3 | -2.354 | -3.234 | -2.175 | -2.232 |
| Distribution rate | - | - | - | - | - | - | - |
| Net sales 1 | - | - | - | - | - | - | 5.66 |
| EBITDA 1 | - | - | - | -26.46 | -25 | -27.75 | -28 |
| EBIT 1 | -6.268 | -11.38 | -19.45 | -26.46 | -37.67 | -40.6 | -47.44 |
| Net income 1 | -8.368 | -11.69 | -19.65 | -24.87 | -45.28 | -57.59 | -69.05 |
| Net Debt 1 | - | - | -48.97 | - | -93.65 | -111.4 | -183.8 |
| Reference price 3 | 2.64 | 5.16 | 9.96 | 7.92 | 13.38 | 13.38 | 13.38 |
| Nbr of stocks (in thousands) | 3,483 | 9,399 | 13,818 | 15,459 | 20,831 | - | - |
| Announcement Date | 30/03/23 | 27/03/24 | 26/03/25 | 27/03/26 | - | - | - |
1CAD in Million2USD in Million3CAD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.14x | - | -4.29x | - | 201M | |
| 20.97x | 7.34x | 14.96x | 1.41% | 70.07B | |
| 30.34x | 7.64x | 23.38x | 0.05% | 52.87B | |
| -78.21x | 14.61x | -74.55x | -.--% | 27.02B | |
| 29.96x | 5.86x | 15.52x | -.--% | 23.61B | |
| -14.6x | 5.15x | -6.71x | -.--% | 23.38B | |
| 60.41x | 21.44x | 43.75x | 0.06% | 19.43B | |
| 25.59x | 4.85x | 16.27x | -.--% | 18.75B | |
| -1206.26x | 37.67x | -14929.22x | -.--% | 15.85B | |
| 15.89x | 4.68x | 10.93x | -.--% | 12.7B | |
| Average | -112.00x | 12.14x | -1,489.00x | 0.17% | 26.39B | |
| Weighted average by Cap. | -60.42x | 10.37x | -890.22x | 0.39% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- MSCL Stock
- Valuation Satellos Bioscience Inc.
Select your edition
All financial news and data tailored to specific country editions
